hepatocellular carcinoma
Conditions
Interventions
Dexamethasone use group:dexamethasone
non use group :N/A
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients with definite preoperative diagnosis who were selected for hepatectomy; No extrahepatic metastasis was found by preoperative imaging examination; Liver function Child Pugh grade A and B; Understand the trial and sign the patient's informed consent form.
Exclusion criteria
Exclusion criteria: Hepatectomy with other organ operations other than cholecystectomy; The tumor obviously invaded the portal vein or hepatic artery; PVE or TACE surgery was performed in the past. Patients with diabetes. Hepatectomy with other organ operations other than cholecystectomy; The tumor obviously invaded the portal vein or hepatic artery; PVE or TACE surgery was performed in the past. Patients with diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| transaminase; under the curve (AUC) of the postoperative course of transaminase.;Peak value of transaminase; | — |
Secondary
| Measure | Time frame |
|---|---|
| total bilirubin;Inflammatory index(PCT/IL-6/CRP);Perioperative complications;blood loss; international normalized ratio;Peak value of total bilirubin;Peak value of inflammatory index; | — |
Countries
China
Contacts
Public ContactLi Jiang
Outcome results
None listed